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To the Editor:
Your recent defense of nonhuman primate research1 rests on assump-
tions of its utility that have little supporting evidence and implies 
that critiques of it are selective and anecdotal. On the contrary, 
the only scientific analyses made to date have been critiques that 
have revealed nonhuman primate models to be of little relevance to 
human medicine.
Some of the most compelling evidence concerns the chimpanzee. 
Over 85% of chimpanzee studies published between 1995 and 2004 
were either not subsequently cited or cited by papers not describing 
human medical progress2,3. The remaining 15% that were subse-
quently cited by human medical studies had not contributed to any 
reported advances in human clinical practice. A recent analysis of 
AIDS vaccine research showed that many of the 85 vaccines tested 
to date in almost 200 clinical trials had been previously tested in 
chimpanzees with positive results, only to fail in humans4. Hepatitis 
C represents another failed attempt at a vaccine, despite almost thirty 
years of effort, a lot of it in nonhuman primates.
Yet HIV infection does not cause AIDS and hepatitis C infection 
does not cause hepatitis in chimpanzees, reflecting the very different 
pathological processes of these viruses in chimpanzees as compared 
to humans. Even studies of why this is so have come up empty handed 
for the benefit of humans, and none of this informs nonhuman pri-
mate researchers who nevertheless persist in claiming they need to 
do more nonhuman primate studies, defying evidence of the lack of 
utility of chimpanzee research and ignoring increasing knowledge 
of the species differences between humans and chimpanzees under-
lying this evidence. For example, significant differences in the full 
gene complement and in gene expression and splicing have been 
shown in a variety of tissues and gene classes5–9, and 80% of the 
orthologous proteins in these two species are different in terms of 
amino acid identity10. 
There is little evidence to support the assertion that other nonhu-
man primate species even more distantly related to humans than 
chimpanzees are valid research models. Many drugs fail in clinical tri-
als despite promising results in preclinical nonhuman primate tests, 
and many that do reach the market cause human harm. Moreover, 
nonhuman primate use in toxicology is no more predictive of human 
response than the use of more evolutionarily distant species.
Further, the ethical perspective cannot be overlooked. For example, 
we have known for years that chimpanzees can acquire American Sign 
Language, demonstrating their complex nonverbal communication 
abilities. They are capable of reasoned thought, abstraction, general-
ization and symbolic representation and have a concept of self. They 
also show a broad range of emotions, experiencing mental, as well 
as physical, pain. Nonhuman primates in captivity show behavioral 
abnormalities and measurable signs of distress, which can result 
from separation of infants from mothers, sensory-motor depriva-
tion or social isolation. Recently, one study reported post-traumatic 
stress disorder in chimpanzees that had been in captivity and used in 
multiple research programs11, and there is unpublished evidence of 
psychological traumas that affect cross-fostered chimpanzees (G.A. 
Bradshaw, T. Capaldo, L. Lindner and G. Grow, unpublished data). 
Such ethical costs combined with little or no scientific worth represent 
serious concern. Combining the two, the argument for the replace-
ment of nonhuman primate research with superior and more humane 
alternatives is formidable.
Alternatives cannot be dismissed using arguments such as ‘whole-
system’ reasoning. The wrong system is the wrong system; whole 
animals may have similar complexities to the human body that can-
not be accurately reflected in vitro, but it is these very complexities 
and their interspecies differences that, when combined, confound 
research results. A collective use of alternative, human-specific meth-
ods obviates this—methods such as three-dimensional human tissue 
culture, microarray-based elucidation of pathology and discovery of 
druggable targets, microfluidic systems, simulated human immune 
system cultures, human tissue bioassays, brain-scanning technolo-
gies and post-mortem examination for studies of brain function 
and neurological disorders, human microdosing for the derivation 
of human-specific pharmacokinetic properties of new drugs, and 
many others.
In summary, systematic study of nonhuman primate research and 
testing suggests that such research has delivered precious little to tangible 
human medical progress. Unless its advocates critically and scientifically 
To the Editor:
The recent Nature Medicine editorial on the use of nonhuman pri-
mates in research 1 presented some of the many sound scientific argu-
ments for why such studies continue to be an essential component 
of medical research. The article also discussed some aspects of the 
ethical dilemma surrounding this work: such experiments may be 
scientifically justified, but is it ‘right’ that we do them?
On this issue, the editorial concluded that “the solid scientific case 
that can be made to support the use of monkeys and apes in research 
must take precedence over ethical arguments until the latter can be 
settled for good.” This position is somewhat unrealistic—the history 
of both this debate and many others in medical ethics tells us that 
such a resolution is unlikely. Even if a resolution is reached within the 
scientific community, it may be more difficult to achieve one amongst 
the wider public, who, after all, are the principal stakeholders.
Furthermore, adopting such a position may give rise to a reality or 
at least a perception in which scientists are distanced from the ethical 
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arguments. This is problematic, because the pivotal point for deci-
sions over whether or not to use animals in research is a cost-benefit 
analysis, where the ‘cost’ is principally couched in terms of probable 
animal suffering. Ethical issues are therefore involved in decision 
making at every stage of the research process, from grant applica-
tions to local ethical review committees and specific experimental 
designs. Most importantly, as scientists, we must continue to have 
an active and vociferous presence in this debate. It is not that the 
scientific case should take precedence over ‘unsettled’ ethical argu-
ments; rather, the scientific case must remain an inextricable part of 
the ongoing ethical debate.
Chris Martin
Experimental Neuroimaging Group, University of Oxford, Parks Road, 
Oxford OX1 3PT, UK. e-mail: chris.martin@dpag.ox.ac.uk
1. Editorial. Nat. Med. 14, 791–792 (2008).
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